Optisol SRL
The score of Optisol shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets +39 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Optisol's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 147,983 € | ||||
| Equity | 555,400 € | ||||
| Cash | 197,175 € | ||||
| EBITDA | 345,915 € | ||||
| Total assets | €1.85m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Optisol's financial analysis
- Solvency30.0%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Optisol
Optisol's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0810.542.589
- VAT number
- BE0810542589
- Peppol
- Registered · 0208:0810542589 · as of 31 Oct 2026
- Legal form
- SRL
- Incorporated
- 17 Mar 2009
- Registered office
- 1320 Beauvechain
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of corrective glasses, lenses and sunglasses (NACE 47742)
Optisol (SRL) has been based in Beauvechain since 2009, active in: retail sale of corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 147,983 € and equity of 555,400 €; its revenue is not published. Its solvency stands at 30.0%, below the median of its sector (46.8%).
Companies similar to Optisol
Companies in the same business, of comparable size and area, outside its group.
- VAN Lindt Manufacture of medical and dental instruments and supplies Tienen · balance sheet €1.17m
- Optiek & Hoorcentrum Joost Manufacture of medical and dental instruments and supplies Lierde · balance sheet 837,528 €
- EYE Candy Manufacture of medical and dental instruments and supplies Leuven · balance sheet 521,568 €
- Het Optiekhuys Retail sale of medical and orthopaedic goods Leuven · balance sheet 996,194 €
- ACE AND Tate Belgium Other non-specialised retail sale Antwerp · balance sheet €1.16m
- 't Brillenhuys Retail sale of medical and orthopaedic goods Leopoldsburg · balance sheet €1.47m
- Matthias Kaulard Retail sale of medical and orthopaedic goods Eupen · balance sheet €1.61m
- Maison Lunettes Retail sale of medical and orthopaedic goods Ostend · balance sheet €1.12m
Frequently asked questions about Optisol
What is the revenue of Optisol?
Optisol files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Optisol?
In Belgium, the VAT number is the company number prefixed with BE: BE0810542589 for Optisol, if the company is VAT-registered. Its company number (CBE) is 0810.542.589.
Where is the registered office of Optisol?
According to the CBE register, the registered office of Optisol is in 1320 Beauvechain.
What is the equity of Optisol?
At the close of the 2025 financial year, the equity of Optisol amounts to 555,400 €, a solvency of 30.0% of total assets.
Who manages Optisol?
The register lists 2 active mandates at Optisol. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Optisol
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →